A focused overview of EU Commission proposals to evolve MDR/IVDR after 10 years, covering simplification, innovation, Notified Body changes, and future regulatory expectations.
At the end of 2025, the European Commission published a series of legislative proposals aimed at refining and adapting the EU Medical Device Regulation (MDR) and In Vitro Diagnostic Regulation (IVDR), marking a decade since their original publication. These proposals seek to strengthen innovation, enhance EU market attractiveness, and improve predictability and transparency, while maintaining the highest standards of patient safety.
During this presentation the proposals and justifications will be explained by discussing the opportunities and challenges related to each recommended measure. Participants will gain clear insights into the evolving legislative landscape and what these changes may mean for future regulatory strategies in the EU.
Key topics include:
Abbott- Conway Park
675 N Field Dr
Lake Forest, IL
RAPS reserves the right to cancel this program at its sole discretion. RAPS will not be responsible for travel or other costs incurred due to cancellation. All cancellation requests must be submitted in writing to [email protected]. Cancellations will receive a full refund minus a 20% administrative fee. RAPS is unable to accept cancellations by phone.
Paid registration substitutions may be accepted with written approval from RAPS for requests received before the start of the event. To transfer a registration, email [email protected] with the event title, name of the original registrant and the contact information for the new attendee.
A certificate of attendance can be downloaded from the RAPS Learning Portal following the event.
Contact the RAPS Support Center:
Call +1 301 770 2920, ext. 200 (8:30 am–5:30 pm EST, Monday–Friday) or email [email protected].


CEO and Owner, B2MAS Holding
Dr. Bassil Akra is CEO and owner of B2MAS Holding which has shares in various companies including AKRA TEAM in Germany (GmbH) and the USA (Inc): a globally acting consultancy company, and RAIANA B.V. in the Netherlands: AI Solution for MedTech Industry. Dr. Akra has advisory board responsibilities in the companies like 3Aware in the US and Milo Health in France. Dr. Akra was the Vice President of Strategic Business Development at the Global Medical Health Services of TÜV SÜD Product Service GmbH. He has vast experience in leadership, business management, research, development, quality management, and regulatory approval of medical devices, combination devices, and ATMP Products. Dr. Akra played an essential role during the implementation of the medical device regulation in Europe. He was also involved in the drafting of several European guidance documents (e.g. MEDDEV, MDCG, etc.) andInternational Standards. He spent the last years of his career at TÜV SÜD training andeducating various stakeholders on EU Legislations. He was also member of the MDR EY Survey Advisory Group and is supporting the various stakeholders’ activities towards the upcoming revision of the EU MDR and EU IVDR. Dr. Akra is also member of the Board ofthe EU Association TEAM PRRC and is supporting the harmonization of the EU Interpretations of this new requirement. Dr. Akra supported the recent cost-saving calculation measures of the EU Commission when drafting the EU MDR and EU IVDR Revision 2 Proposal.
We have completed our migration to a new platform and are pleased to introduce the updated site.
What to expect: If you have an existing login, please RESET YOUR PASSWORD before signing in. After you log in for the first time, you will be prompted to confirm your profile preferences, which will be used to personalize content.
We encourage you to explore the new website and visit your updated My RAPS page. If you need assistance, please review our FAQ page.
We welcome your feedback. Please let us know how we can continue to improve your experience.